Lessons Learned about the Need for Early Screening for Depression during the First Months of the COVID-19 Pandemic in the United States

Abstract

A nationwide survey assessed the prevalence and pandemic-related risk factors of major depressive disorder (MDD) at the initial onset of the COVID-19 pandemic. Findings showed a significant increase in the prevalence of MDD (22.7%) compared to the pre-pandemic 12-month estimate (10.4%). Specific pandemic-related concerns, along with significant increases in stress, loneliness, fatigue, and substance use behaviors are noted for those with the provisional diagnosis of MDD. Early screening and detection for potential MDD cases can reduce the severity and duration of maladaptive symptoms, decreasing the risk for future depression episodes and the potential loss of quality of life and productivity.

Disclosure statement

The authors report no conflicts of interest.

Additional information

Funding

The work was supported by internal funding provided by the Department of Psychology at Texas Stated University.